Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse

Kidney International

Volumn 74, Issue 1, 2008, Pages 47-51

  Juncos, J P ^a   Tracz, M J ^a   Croatt, A J ^a   Grande, J P ^a   Ackerman, A W ^a   Katusic, Z S ^a,b   Nath, K A ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Arteriovenous access; Arteriovenous fistula; Arteriovenous graft; Chronic dialysis; Heme oxygenase

Indexed keywords

GELATINASE A; GELATINASE B; HEME OXYGENASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS FISTULA; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME DEFICIENCY; GENE EXPRESSION REGULATION; GENETIC DISORDER; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

EID: 45249094495     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.110     Document Type: Article

References (35)

1. Hakim R, Himmelfarb J. Hemodialysis access failure: a call to action. Kidney Int 1998; 54: 1029-1040.
2. Schwab SJ. Improving access patency: pre-end-stage renal disease strategies. J Am Soc Nephrol 1998; 9: S124-S129.
3. Roy-Chaudhury P, Kelly BS, Zhang J et al. Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Blood Purif 2003; 21: 99-110.
4. Konner K, Nonnast-Daniel B, Ritz E. The arteriovenous fistula. J Am Soc Nephrol 2003; 14: 1669-1680.
5. Roy-Chaudhury P, Kelly BS, Melhem M et al. Vascular access in hemodialysis: issues, management, and emerging concepts. Cardiol Clin 2005; 23: 249-273.
6. Dixon BS. Why don't fistulas mature? Kidney Int 2006; 70: 1413-1422.
7. Dixon BS. Weighing in on fistula failure. Kidney Int 2007; 71: 12-14.
8. Roy-Chaudhury P, Spergel LM, Besarab A et al. Biology of arteriovenous fistula failure. J Nephrol 2007; 20: 150-163.
9. Kanwar YS. Functional duality of progenitor cells influxing into arteriovenous fistula during its neoangiogenesis. Am J Physiol Renal Physiol 2007; 293: F468-F469.
10. Ravani P, Spergel LM, Asif A et al. Clinical epidemiology of arteriovenous fistula in 2007. J Nephrol 2007; 20: 141-149.
11. Schwab SJ. Hemodialysis vascular access: the Achilles' heel remains. Kidney Int 2007; 72: 665-666.
12. Roy-Chaudhury P, Kelly BS, Miller MA et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 2001; 59: 2325-2334.
13. Lin CC, Yang WC, Lin SJ et al. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 2006; 69: 165-172.
14. Castier Y, Lehoux S, Hu Y et al. Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model. Kidney Int 2006; 70: 315-320.
15. Nath KA, Balla G, Vercellotti GM et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992; 90: 267-270.
16. Agarwal A, Nick HS. Renal response to tissue injury: lessons from heme oxygenase-1 GeneAblation and expression. J Am Soc Nephrol 2000; 11: 965-973.
17. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005; 39: 1-25.
18. Chen S, Kapturczak MH, Wasserfall C et al. Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc Natl Acad Sci USA 2005; 102: 7251-7256.
19. Nath KA. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 2006; 70: 432-443.
20. Hill-Kapturczak N, Agarwal A. Haem oxygenase-1: a culprit in vascular and renal damage? Nephrol Dial Transplant 2007; 22: 1495-1499.
21. Orozco LD, Kapturczak MH, Barajas B et al. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res 2007; 100: 1703-1711.
22. Castier Y, Brandes RP, Leseche G et al. p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res 2005; 97: 533-540.
23. Ram M, Sherer Y, Shoenfeld Y. Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol 2006; 26: 299-307.
24. Newby AC. Do metalloproteinases destabilize vulnerable atherosclerotic plaques? Curr Opin Lipidol 2006; 17: 556-561.
25. Chen YH, Lin SJ, Lin MW et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 2002; 111: 1-8.
26. Exner M, Minar E, Wagner O et al. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 2004; 37: 1097-1104.
27. Brydun A, Watari Y, Yamamoto Y et al. Reduced expression of heme oxygenase-1 in patients with coronary atherosclerosis. Hypertens Res 2007; 30: 341-348.
28. Fujita T, Toda K, Karimova A et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 2001; 7: 598-604.
29. Nath KA, Vercellotti GM, Grande JP et al. Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int 2001; 59: 106-117.
30. Pittock ST, Norby SM, Grande JP et al. MCP-1 is upregulated in unstressed and stressed HO-1 knockout mice: pathophysiologic correlates. Kidney Int 2005; 68: 611-622.
31. Murali NS, Ackerman AW, Croatt AJ et al. Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. Am J Physiol Renal Physiol 2007; 292: F837-F844.
32. -/- mice. Am J Pathol 2007; 170: 1820-1830.
33. Diaz Encarnacion MM, Griffin MD, Slezak JM et al. Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. Am J Transplant 2004; 4: 248-256.
34. Zhao H, Ito A, Sakai N et al. RECS1 is a negative regulator of matrix metalloproteinase-9 production and aged RECS1 knockout mice are prone to aortic dilation. Circ J 2006; 70: 615-624.
35. Gerlach RF, Demacq C, Jung K et al. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Clin Biochem 2007; 40: 119-123.